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Recent advances in the analysis of antibiotics
by capillary electrophoresis
In this review, the main aspects related to the separation of different groups of antibi-
otics by CE as well as the different applications reported in the literature from the
beginning 2003 till May 2005 will be provided to the readers. Firstly, the experimental
conditions employed to achieve the analysis of antibiotics by CE are given. Then, the
main applications performed in the pharmaceutical, clinical, food, and environmental
fields have been reviewed making emphasis on sample preparation requirements
needed in each case. Finally, the main conclusions and future prospects in this field are
presented.
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1 Introduction
The term “antibiotic” refers to a very diverse range of
chemical substances (produced from bacteria or fungi
(natural way) or in a semisynthetic or synthetic way) that
possess antibacterial activity, that is, that kill or inhibit the
growth of microorganisms. They are used in human and
animal medicine to prevent and treat diseases (European
Medicines Agency, http://www.emea.eu.int/; checked on
May 2005) [1].
Although HPLC is mainly used for the analysis of antibi-
otics by separation techniques, CE is being increasingly
employed due to its favorable characteristics (high effi-
ciency, large flexibility, and low consumption of samples
and reagents). In addition, CE is being used in routine
analysis because it allows obtaining appropriate analyti-
cal characteristics and good quantitative results. The
analysis of antibiotics by CE is mainly included in two dif-
ferent working modes: (i) CZE where a separation buffer
without or with additives is used for the separation of ionic
or ionogenic antibiotics based on their different electro-
phoretic mobilities, and (ii) MEKC where a micellar system
(surfactant at a concentration higher than its CMC) is
added to the separation buffer to perform the separation
of neutral and/or ionic or ionogenic antibiotics based on
the generation of a pseudostationary phase in which
analyte partition takes place. Although much less used,
CEC and nonaqueous CE (NACE) have also been used for
the analysis of antibiotics [2].
In order to provide to the readers an updated view of the
separation conditions as well as the different applications
reported in the analysis of antibiotics using CE as
separation technique, this review covers the literature
dealing on the analysis of antibiotics by CE from the
beginning of 2003 till May 2005. Literature published
before this date on this subject has already been reviewed
by Flurer [2–5]. The experimental conditions employed to
achieve the analysis of antibiotics by CE are first pre-
sented in this article. Section 3 of this work describes the
main applications performed in the pharmaceutical, clin-
ical, food, and environmental fields making emphasis on
sample preparation requirements needed in each case.
Finally, the main conclusions and future prospects in this
field are presented.
2 Analysis of antibiotics by CE
Table 1 summarizes the antibiotics analyzed during the
last 2.5 years using CE as the separation technique. They
have been classified in different antibiotic groups indicat-
ing their molecular formula, formula weight, CAS number
(number assigned by the Chemical Abstract Service
(CAS) to identify a specific chemical compound), and
structure. In addition to the CE separation conditions, the
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Table 1. Group, substance, molecular formula, formula weight, CAS number, structure, CE separation conditions, detec-
tion system, and LODs of the antibiotics included in this review
Group of
antibiotic
Substance Molecular
formula
(formula
weight)a)
CAS
numberb)
Structure CE separation
conditions
Detection
(LOD)
Refer-
ence
-Lactam
anti-
biotics
Ampicillin C16H19N3O4S
(349.40)
69-53-4 40 mM phosphate-
borate
(pH 7.5) 1 75 mM
SDS (capillary 50 cm
(57 cm)650 mm ID;
23–30 kV; 257C)
UV-200 nm
(0.1%)
[6]
40 mM borate
(pH 8.5) 1 100 mM
SDS (capillary 50 cm
(57 cm)675 mm ID;
10 kV; 207C)
UV-210 nm
(0.2 mg/mL)
[7]
20 mM borate
(pH 8)1 60 mM SDS
(capillary 55.5 cm
(64 cm)675 mm ID;
15 kV; 257C)
UV-210 nm
(0.015
mg/mL)
[8]
Penicillin V C16H17N2O5SK
(388.48)
132-98-9 40 mM borate
(pH 8.5) 1 100 mM
SDS (capillary 50 cm
(57 cm)675 mm ID;
10 kV; 207C)
UV-210 nm
(0.15 mg/mL)
[7]
20 mM borate
(pH 8)1 60 mM SDS
(capillary 55.5 cm
(64 cm)675 mm ID;
15 kV; 257C)
UV-210 nm
(0.005
mg/mL)
[8]
Penicillin G C16H17KN2O4S
(372.48)
113-98-4 40 mM borate
(pH 8.5) 1 100 mM
SDS (capillary 50 cm
(57 cm)675 mm ID;
10 kV; 207C)
UV-210 nm
(0.3 mg/mL)
[7]
10 g/L phosphate-
borate
(pH 8.7) 1 14.4 g/L
SDS (capillary 52 cm
(60 cm)675 mm ID;
18 kV; 257C)
UV-214 nm
(1 mg/mL)
[9]
80 mM borate (pH 8.0)
(capillary
60 cm675 mm ID;
15 kV; 357C)
UV-185 nm
(3.5 mg/mL)
[10]
20 mM borate
(pH 8)1 60 mM SDS
(capillary 55.5 cm
(64 cm)675 mm ID;
15 kV; 257C)
UV-210 nm
(0.005
mg/mL)
[8]
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Table 1. Continued
Group of
antibiotic
Substance Molecular
formula
(formula
weight)a)
CAS
numberb)
Structure CE separation
conditions
Detection
(LOD)
Refer-
ence
Amoxicillin C16H19N3O5S
(365.40)
26787-
78-0
5–25 mM phosphate-
borate (capillary
47–77 cm6
75–100 mm ID;
25 kV; 257C)
UV-200 nm
(0.015
mg/mL)
[11]
40 mM borate
(pH 8.5) 1 100 mM
SDS (capillary 50 cm
(57 cm)675 mm ID;
10 kV; 207C)
UV-210 nm
(0.3 mg/mL)
[7]
20 mM borate
(pH 8)1 60 mM SDS
(capillary 55.5 cm
(64 cm)675 mm ID;
15 kV; 257C)
UV-210 nm
(0.025
mg/mL)
[8]
Oxacillin C19H18N3
NaO5S?
H2O
(441.43)
7240-
38-2
40 mM borate
(pH 8.5) 1 100 mM
SDS (capillary 50 cm
(57 cm)675 mm ID;
10 kV; 207C)
UV-210 nm
(0.2 mg/mL)
[7]
20 mM borate
(pH 8)1 60 mM SDS
(capillary 55.5 cm
(64 cm)675 mm ID;
15 kV; 257C)
UV-210 nm
(0.005
mg/mL)
[8]
Cloxacillin C19H17ClN3
NaO5S
(457.86)
642-78-4 40 mM borate
(pH 8.5) 1 100 mM
SDS (capillary 50 cm
(57 cm)675 mm ID;
10 kV; 207C)
UV-210 nm
(0.2 mg/mL)
[7]
20 mM borate
(pH 8)1 60 mM SDS
(capillary 55.5 cm
(64 cm)675 mm ID;
15 kV; 257C)
UV-210 nm
(0.005
mg/mL)
[8]
Diclo-
xacillin
C19H16Cl2N3
O5SNa?
H2O
(492.31)
13412-
64-1
20 mM borate
(pH 8)1 60 mM SDS
(capillary 55.5 cm
(64 cm)675 mm ID;
15 kV; 257C)
UV-210 nm
(0.005
mg/mL)
[8]
Nafcillin – – 20 mM borate
(pH 8)1 60 mM SDS
(capillary 55.5 cm
(64 cm)675 mm ID;
15 kV; 257C)
UV-210 nm
(0.015
mg/mL)
[8]
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Table 1. Continued
Group of
antibiotic
Substance Molecular
formula
(formula
weight)a)
CAS
numberb)
Structure CE separation
conditions
Detection
(LOD)
Refer-
ence
Ticarcillin C15H14N2
Na2O6S2
(428.39)
4697-14-7 20 mM phosphate-
borate
(pH 8.66) 1 1.44%
SDS (capillary
60 cm675 mm ID;
18 kV; 257C)
UV-214 nm
(1.5 mg/mL)
[12]
Cephalexin C16H17N3
O4S?xH2O
(347.39)
15686-
71-2
20 mM borate
(pH 9.23) 1 20 mM
SDS1 1% Brij 35
(capillary 28 cm
(50 cm)675 mm ID;
15 kV; 307C)
UV-210 nm
(2 mg/mL)
[13]
Cefazolin C14H13N8
NaO4S3
(476.49)
27164-
46-1
25 mM phosphate
(pH 6.8) (capillary
40 cm
(48.5 cm)650 mm
ID; 25 kV; 257C)
UV-270 nm [14]
Aminogly-
coside
anti-
biotics
Kanamycin
B
C18H37N5O10
(581.59)
29701-
07-3
R1 = –H, R2 = –NH2, R3 = –OH, R4 =
–OH, R5 = –CH2NH2, R6 = –H, R7 =
–H, R8 = –CH2OH
30 mM borate
(pH 10.0) 1 16%
methanol (capillary
31.5 cm
(40 cm)650 mm ID;
15 kV; 207C)
UV-335 nm
(OPA deriva-
tive;
,0.6 mg/
mL)
[17]
Amikacin – 149022-
22-0
R1 = –COCH(CH3)2CH2NH2, R2 = –OH,
R3 = –OH, R4 = –OH, R5 = –CH2NH2,
R6 = –H, R7 = –H, R8 = –CH2OH
100 mM borate
(pH 10.0) 1 20 mM
deoxy-
cholate 1 15 mM b-
CD (capillary
24.5 cm650 mm ID;
12 kV; 257C)
UV-340 nm
(OPA
derivative)
[15]
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Table 1. Continued
Group of
antibiotic
Substance Molecular
formula
(formula
weight)a)
CAS
numberb)
Structure CE separation
conditions
Detection
(LOD)
Refer-
ence
Tobramycin C18H37N5O9
(467.51)
32986-
56-4
R1 = –H, R2 = –NH2, R3 = –H, R4 =
–OH, R5 = –CH2NH2, R6 = –H, R7 =
–H, R8 = –CH2OH
100 mM borate
(pH 10.0) 1 20 mM
deoxy-
cholate 1 15 mM b-
CD (capillary
24.5 cm650 mm ID;
12 kV; 257C)
UV-340 nm
(OPA
derivative)
[15]
Gentamicin
(C1, C1a,
C2a, C2)
– 1405-
41-0
R1 = –H, R2 = –NH2, R3 = –H, R4 = –H,
R5 = –CH(NH2)CH3, R6 = –CH3, R7 =
–CH3, R8 = –H
100 mM borate
(pH 10.0) 1 20 mM
deoxy-
cholate 1 15 mM b-
CD (capillary
24.5 cm650 mm ID;
12 kV; 257C)
UV-340 nm
(OPA
derivative)
[15, 16]
1 mM citrate
(pH 3.5) 1 0.2 mM
CTAB (capillary
53 cm650 mm ID;
15 kV; 257C)
Potential
gradient
detection
(,9 mg/mL)
[18]
60 mM CHES
(pH 9.5) 1 31.6%
methanol (capillary
40 cm
(50.2 cm)675 mm
ID; 23 kV; 207C)
UV-230 nm
(,0.0001
mg/L)
[25]
Sisomicin 2C19H37
N5O7?
5H2O4S
(1385.45)
53179-
09-2
R1 = –H, R2 = –NH2, R3 = –H, R4 = –H,
R5 = –CH2NH2, R6 = –CH3, R7 = –CH3,
R8 = –H
100 mM borate
(pH 10.0) 1 20 mM
deoxy-
cholate 1 15 mM b-
CD (capillary
24.5 cm650 mm ID;
12 kV; 257C)
UV-340 nm
(OPA
derivative)
[15, 16]
Netilmicin C21H41N5
O7?2.5H2
O4S
(720.78)
56391-
57-2
R1 = –C2H5, R2 = –NH2, R3 = –H,
R4 = –H, R5 = –CH2NH2, R6 = –CH3,
R7 = –CH3, R8 = –H
100 mM borate
(pH 10.0) 1 20 mM
deoxy-
cholate 1 15 mM b-
CD (capillary
24.5 cm650 mm ID;
12 kV; 257C)
UV-340 nm
(OPA
derivative)
[15, 16]
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Table 1. Continued
Group of
antibiotic
Substance Molecular
formula
(formula
weight)a)
CAS
numberb)
Structure CE separation
conditions
Detection
(LOD)
Refer-
ence
Dihydro-
strepto-
mycin
C21H41N7O12?
3/2H2SO4
(730.71)
5490-
27-7
R = –CH2OH 80 mM borate (pH 8.0)
(capillary
60 cm675 mm ID;
15 kV; 357C)
UV-185 nm
(15 mg/mL)
[10]
Streptomy-
cin
2C21H39
N7O12?
(H2SO4)3
(1457.38)
3810-
74-0
R = –CHO 20 mM phosphate-
borate (capillary
47 cm6100 mm ID;
25 kV; 257C)
UV-200 nm
(0.04 mg/mL)
[11]
Glyco-
peptide
anti-
biotics
a-Avoparcin
(R = –H)
b-Avo-
parcin (R
= –Cl)
– – 20 mM borate
(pH 9.2) 1 75 mM
SDS (capillary 50 cm
(57 cm)675 mm ID;
15 kV; 307C)
UV-200 nm
(,0.01
mg/mL)
[19]
Risto-
cetin A
Risto-
cetin B
– –
Ristobiose[O-a-L-rhamnopyranosyl-
(1–6)-O-b-D-glucopyranosyl] rather than
ristotetrose[O-a-D-arabinofuranosyl-
(1–2)-O-a-D-mannopyranosyl-(1–2)-
O-a-L-rhamnopyranosyl-(1–6)-O-
b-D-glucopyranosyl] is attached to ring II in
Ristocetin B
Vancomycin C66H75Cl2
N9O24
HCl?xH2O
(1485.71)
123409-
00-7
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Table 1. Continued
Group of
antibiotic
Substance Molecular
formula
(formula
weight)a)
CAS
numberb)
Structure CE separation
conditions
Detection
(LOD)
Refer-
ence
Sulfonamide
anti-
biotics
Sulfame-
thazine
C12H14N4
O2S
(278.33)
57-68-1 35 mM phosphate
(pH 6.5) (capillary
72 cm
(80.5 cm)650 mm
ID; 25 kV; 257C)
UV-205 nm
(,0.005
mg/mL)
[20]
Sulfame-
razine
C11H12N4O2S
(264.30)
127-79-7
Sulfadiazine C10H10N4O2S
(250.28)
68-35-9
Sulfadime-
thoxine
C12H14N4O4S
(310.33)
122-11-2
Sulfamono-
methoxine
C11H12N4O3S
(280.30)
1220-83-3
Sulfa-
phenazole
C15H14N4O2S
(314.36)
526-08-9
Sulfa-
quinoaline
– –
Sulfisoxa-
zole
C11H13N3O3S
(267.30)
127-69-5
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Table 1. Continued
Group of
antibiotic
Substance Molecular
formula
(formula
weight)a)
CAS
numberb)
Structure CE separation
conditions
Detection
(LOD)
Refer-
ence
Tetracycline
anti-
biotics
Tetra-
cycline
C22H24N2
O8?xH2O
(444.43)
60-54-8 R1 = –H, R2 = –CH3, R3 = –OH, R4 = –H 50 mM citric acid
(pH 2.5) (capillary
37 cm675 mm ID;
10 kV; 257C)
UV-260 nm
(,0.002
mg/mL)
[21]
Oxytetra-
cycline
C22H24N2
O9?2H2O
(496.46)
6153-
64-6
R1 = –H, R2 = –CH3, R3 = –OH, R4 = –OH
Doxy-
cycline
C22H24N2O8
HCl 1/2
(H2O) 1/2
(C2H6O)
(512.94)
24390-
14-5
R1 = –H, R2 = –CH3, R3 = –H, R4 = –OH
Fluoroquino-
lone anti-
biotics
Ofloxacin C18H20FN3O4
(361.37)
82419-
36-1
R1 = –CH3, R2 = –CH(CH3)CH2O– = R3 50 mM phosphate
(pH 2.8) 1 40 mg/mL
methyl b-CD
(capillary 30 cm
(37 cm)650 mm ID;
20 kV; 257C)
UV-280 nm
(0.003
mg/mL of
each enan-
tiomer)
[22]
Enro-
floxacin
C19H22FN3O3
(359.39)
93106-
60-6
R1 = –CH2CH3, R2 = , R3 = –H 25 mM phosphate-
borate (capillary
77 cm675 mm ID;
25 kV; 257C)
UV-280 nm
(0.005–
0.003
mg/mL)
[11]
Cipro-
floxacin
C17H18FN3O3
(331.34)
85721-
33-1
R1 = –H, R2 = , R3 = –H
Norfloxacin C16H18FN3O3
(319.33)
70458-
96-7
R1 = –H, R2 = –CH2CH3, R3 = –H
Other anti-
biotics
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Table 1. Continued
Group of
antibiotic
Substance Molecular
formula
(formula
weight)a)
CAS
numberb)
Structure CE separation
conditions
Detection
(LOD)
Refer-
ence
Florphenicol C12H14Cl2
FNO4S
(358.21)
73231-
34-2
R1 = –SO2CH3, R2 = –COCHCl2, R3 = –F 25 mM phosphate-bo-
rate (capillary
57 cm675 mm ID;
25 kV; 257C)
UV-200 nm
(0.015/
0.008 mg/
mL)
[11]
50 mM borate
(pH 9.0) 1 25 mM
SDS (capillary
52.5 cm
(60 cm)675 mm ID;
15 kV; 207C)
UV-214 nm [23]
Thiam-
phenicol
C12H15Cl2
NO5S
(356.22)
15318-
45-3
R1 = –SO2CH3, R2 = –H, R3 = –OH
Chloram-
phenicol
Cl2CHCON
HCH(CH2
OH)CH
(OH)C6H4
NO2
(323.13)
56-75-7 R1 = –NO2, R2 = –COCHCl2, R3 = –OH 50 mM borate
(pH 9.0) 1 25 mM
SDS (capillary
52.5 cm
(60 cm)675 mm ID;
15 kV; 207C)
UV-214 nm [23]
Fosfomycin C3H5O4PNa2
(182.02)
26016-
99-9
25 mM benzoic
acid 1 0.5 mM CTAB
(pH 6.95 or 8.05)
(capillary 56 cm
(64.5 cm)650 mm
ID; -25 kV; 257C)
Indirect UV-
254 nm
(1 mg/mL)
[24]
Brij 35: lauryl polyoxyethylene ether.
a) Information obtained from (Sigma-Aldrich, http://www.sigmaaldrich.com; checked on May 2005 ).
b) CAS number: the number assigned by the Chemical Abstract Service (CAS) to identify specific chemical compounds. A
chemical may have more than one CAS number. Not all chemicals have an assigned CAS number (California pesticide
information portal terms and definitions, http://calpip.cdpr.ca.gov/cfdocs/calpip/prod/infodocs/glossary.cfm; checked
on May 2005).
detection conditions employed and the LODs determined
for the different antibiotics included in this review are
indicated in the table. The results obtained in the analysis
of antibiotics by CE are presented as follows, including
first the most widely analyzed by this technique.
2.1 -Lactam antibiotics
b-Lactam antibiotics can be classified into several groups
according to their structural characteristics, but their
unique structural feature is the presence of the four-
membered b-lactam (2-azetidinone) ring. They include
penicillins and cephalosporins (also aminocillins,
carbapenems, and monobactams) (b-lactam antibiotics,
http://www.cic.klte.hu/,gundat/betalaca.htm; checked
on May 2005). Penicillins included in this review, ampi-
cillin, penicillin V, penicillin G, amoxicillin, oxacillin, clox-
acillin, dicloxacillin, nafcillin, and ticarcillin, have been
separated using borate or phosphate-borate buffers at
basic pH usually with SDS micelles [6–12]. As example,
Fig. 1 shows the separation of a mixture of eight of these
penicillins in borate buffer at pH 8 with SDS micelles in
about 20 min after an on-column sample preconcentra-
tion by stacking [8]. In addition, the use of UV-detection at
low wavelengths (from 185 to 214 nm) enabled to obtain
LODs ranging from 0.005 to 1.5 mg/mL (see Table 1). The
cephalosporins cephalexin and cefazolin have also been
separated by CE. Cephalexin has been analyzed using
borate buffer at pH 9.23 in combination with an anionic
© 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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Figure 1. Separation of eight
different penicillins by CE. Elec-
trophoretic conditions: fused-
silica capillary, ld = 55.5 cm, lt =
64 cm, and 75 mm ID; separa-
tion buffer, 20 mM borate (pH 8)
containing 60 mM SDS; separa-
tion temperature, 257C; applied
voltage, 15 kV; hydrodynamic
injection of 50 mbar for 360 s
followed by reverse electrode polarity stacking (up to 95% of the buffer current intensity was reached). UV-detection at
210 nm. Peak identification: 1, amoxicillin; 2, penicillin G; 3, ampicillin; 4, oxacillin; 5, penicillin V; 6, cloxacillin; 7, nafcillin;
8, dicloxacillin. Reprinted from [8], with permission.
surfactant (SDS) and a neutral surfactant (lauryl poly-
oxyethylene ether, Brij 35) achieving LODs in the mg/mL
range when UV-detection at 210 nm was used [13]. For
the analysis of cefazolin, a phosphate buffer at pH 6.8 and
UV-detection at 270 nm was employed [14].
2.2 Aminoglycoside antibiotics
Aminoglycoside antibiotics include a variety of related
amino sugars joined via glycoside linkages. The ami-
noglycoside antibiotics included in this review are kana-
mycin, amikacin, tobramycin, gentamicin, sisomicin,
netilmicin, as well as dihydrostreptomycin and strepto-
mycin (see Table 1). Whereas most of these antibiotics are
characterized by one main component accompanied by
some minor components, gentamicin consists of four
major components (C1, C1a, C2, and C2a). Because of the
lack of UV chromophore groups in these antibiotics, deri-
vatization is usually required prior to UV-detection. Thus,
precolumn derivatization with 1,2-phthalic dicarbox-
aldehyde (OPA) was employed to analyze amikacin,
tobramycin, gentamicin, sisomicin, and netilmicin using
borate buffer at pH 10 in presence of the bile salt deox-
ycholate and the native b-CD used to enlarge the
separation window [15, 16]. Under these experimental
conditions, the separation of the four major components
of gentamicin in a commercial sample from the derivati-
zation agent (OPA) and an internal standard (IS) was
achieved and it is illustrated in Fig. 2 as example. An
interesting on-column derivatization with OPA was also
performed to detect kanamycin B using borate buffer at
pH 10 modified with methanol as BGE [17]. In addition,
potential gradient detection was also employed for the
analysis of gentamicin components when the separation
was achieved with citrate buffer at pH 3.5 in presence of
the cationic surfactant CTAB. This is a universal detector
based on measuring the mobility differences between
sample molecules and the separation buffer’s co-ions,
that is, the potential gradient along the axis of the capil-
Figure 2. Separation of the major components of genta-
micin by CE. Electrophoretic conditions: fused-silica
capillary, ld = 24.5 cm, lt = 33.0 cm, and 50 mm ID;
separation buffer, 100 mM borate (pH 10.0) containing
20 mM deoxycholate and 15 mM b-CD; separation tem-
perature, 257C; applied voltage, 12 kV; hydrodynamic
injection 50 mbar for 5 s. UV-detection at 340 nm. Re-
printed from [15], with permission.
lary. LODs in the mg/mL range were achieved using this
detection system [18]. The aminoglycosides dihydro-
streptomycin and streptomycin were detected at the non-
selective low wavelengths of 185 or 200 nm using borate
or borate-phosphate buffers at basic pH (see Table 1). In
fact, the analysis of these antibiotics using borate buffers
at basic pH enables the formation of UV-absorbing borate
complexes which can be detected by UV-detection. LODs
of 15 and 0.04 mg/mL for dihydro-streptomycin and strep-
tomycin, respectively, were reported [10, 11].
2.3 Glycopeptide antibiotics
Glycopeptide antibiotics are composed of a peptide
aglycone, neutral sugars, and an amino sugar. These
aglycones consist of heptapeptides of cross-linked un-
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Figure 3. Separation of five glycopeptide antibiotics by
CE. Electrophoretic conditions: fused-silica capillary, ld =
50 cm, lt = 57 cm, and 75 mm ID; separation buffer, 20 mM
borate (pH 9.2) containing 75 mM SDS; separation tem-
perature, 307C; applied voltage, 15 kV; hydrodynamic
injection for 15 s. UV-detection at 200 nm. Peak identifi-
cation: 1, ristocetin A; 3, ristocetin B; 5, b-avoparcin;
6, vancomycin; 7, a-avoparcin; peaks 2 and 4 are minor
components of ristocetin and avoparcin. Reprinted from
[19], with permission.
usual aromatic amino acids, and conventional amino
acids such as aspartic acid (see Table 1). Vancomycin,
avoparcin, and ristocetin are members of this group of
antibiotics. They are soluble in aqueous or polar organic
solvents but insoluble in nonpolar organic solvents. Van-
comycin, ristocetin, and avoparcin, the two latter in their
two biological active forms (a- and b-avoparcin and ris-
tocetin A and B), were separated by CE using borate
buffer at pH 9.2 in presence of anionic micelles of SDS.
Although these glycopeptides have similar pIs, they form
borate complexes, which in the presence of the SDS
micelles have sufficiently different net electrophoretic
mobilities to allow their baseline separation as it is shown
in Fig. 3. Due to their UV-absorption they were detected
at 200 nm [19].
2.4 Sulfonamide antibiotics
Sulfonamide antibiotics are organic compounds posses-
sing an amide of a sulfonic acid (see Table 1). The eight
sulfonamides sulfamethazine, sulfamerazine, sulfadia-
zine, sulfadimethoxine, sulfamonomethoxine, sulfaphe-
nazole, sulfaquinoaline, and sulfisoxazole were baseline
separated with a 35 mM phosphate buffer at pH 6.5 in
less than 15 min. They were detected registering their UV-
absorption at 205 nm [20].
2.5 Tetracycline antibiotics
Tetracyclines are structurally related compounds with
multiple functional groups with acid–base properties,
whose presence confers them an amphoteric character.
In fact, most of these compounds exhibit an pI be-
tween 4 and 6. Since in alkaline media tetracyclines oxi-
dized easily, citric acid at pH 2.5 was used for the
separation of the three tretracycline antibiotics tetra-
cycline, oxytetracycline, and doxycyline obtaining good
results in terms of resolution and sensitivity. The UV-
absorption of these compounds at 260 nm was regis-
tered to detect them [21].
2.6 Fluoroquinolone antibiotics
Fluoroquinolone antibiotics form a group of broad-
spectrum antibiotics derived from nalidixic acid. Enro-
floxacin and norfloxacin, two of the most frequently
used fluoroquinolones, were separated in about 11 min
in a phosphate-borate buffer at basic pH [11]. In addi-
tion, the separation of the enantiomers of the chiral
fluoroquinolone ofloxacin was achieved in phosphate
buffer at acid pH (2.8) when methyl b-CD was used as
chiral selector. Under these conditions, the detection of
the enantiomers was performed at 280 nm [22]. This is
the only enantiomeric separation of a chiral antibiotic by
CE reported during the period of time reviewed in this
article.
2.7 Other antibiotics
The antibiotics florphenicol, thiamphenicol, and chloram-
phenicol are structural analogs as it can be observed in
Table 1. They were baseline separated in about 6 min
using a borate buffer at pH 9 in presence of SDS micelles
[23]. In addition, using phosphate-borate buffer the
detection of florphenicol and thiamphenicol was per-
formed at 200 nm [11].
Fosfomycin is an antibiotic possessing an epoxy moiety
and phosphonic acid functions (see its structure in
Table 1). This compound, which has very low molecular
weight, two pKas (2.0 and 6.4), and lack of absorption in
the UV-region, was detected in the mg/mL range using in-
direct UV-absorption at 254 nm. Analysis of this antibiotic
was achieved using benzoic acid as electrolytic solution
containing a very low concentration of the cationic sur-
factant CTAB at neutral or slightly basic pHs depending
on the sample analyzed [24].
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3 Applications
The papers dealing with the analysis of antibiotics using
CE as the separation technique during the period of time
reviewed in this article were focused on the analysis of
pharmaceutical preparations, biological samples, food
samples, and environmental samples as it is illustrated in
Table 2. This table shows the samples studied, the sam-
ple treatment followed, the antibiotics analyzed, and a
brief description of the main conditions employed for their
analysis by CE.
3.1 Antibiotics in pharmaceutical preparations
The analysis of antibiotics is of critical importance during
their synthesis as well as for the quality control of their
pharmaceutical preparations. Different pharmaceutical
preparations were analyzed during the period of time
reviewed in this work. They included formulations for
preparing injection solutions, capsules, veterinary prep-
arations, solutions, oral suspensions, as well as different
drugs to assess their purity (see Table 2). Very easy
sample treatments were followed to analyze these sam-
ples. Thus, aqueous or buffer solutions of b-lactam,
aminoglycoside antibiotics, and thiamphenicol analogs,
and solutions resulting from the derivatization of the
aminoglycoside gentamicine were directly injected in the
CE system.
Ampicillin was determined in powder for preparing injec-
tion solutions from two different manufacturers and in
capsules using phosphate-borate buffer (pH 7.5) with
SDS micelles after dissolution in phosphate buffer at
pH 7.0. However, when preparing samples from cap-
sules, solutions were sonicated and filtered prior to injec-
tion in the CE system. It was shown that this method was
suitable for the routine control of purity of ampicillin bulk
substances and pharmaceuticals, such as capsules and
injections, with quantitation limits lower than 0.4% [6].
The simultaneous analysis of ticarcillin (b-lactam antibi-
otic/carboxypenicillin) and clavulanic acid (b-lactamase
inhibitor), which are combined in Timentin preparations,
was achieved using a phosphate-borate buffer (pH 8.7)
with SDS micelles after dissolution of the pharmaceutical
preparation in water. In this work, the quantitation limit of
the antibiotic ticarcillin for the Timentin preparation was
established in the concentration of 40 mg/mL [12].
The identification and simultaneous determination of
dihydrostreptomycin and penicillin G (also its procaine
salt) present in a multiantibiotic veterinary preparation
(Veti-ps preparation) was achieved by CE using borate
buffer at pH 8.0. In this work, sample solutions were pre-
pared in water and diluted properly prior to the injection in
the CE system achieving LOQs of 50 mg/mL for dihydro-
streptomycin and 12 mg/mL for penicillin G [10].
The quantitative determination of chloramphenicol, flor-
fenicol, and thiamphenicol in capsules and solutions was
performed by CE using borate buffer (pH 9.0) containing
SDS micelles. Water solutions were filtered prior to injec-
tion in the CE system. The analysis of different placebo
mixtures showed that several excipients (lactose, talc,
magnesium stearate, dextran, methyl para-
hydroxybenzoate N-methyl-2-pyrrolidone, propylene
glycol, macrogol 300, and hypromellose) did not
adversely affect the results [23].
The analysis of cephalexin in a commercially available
oral suspension prepared by its appropriate dilution in
water was achieved by CE using borate buffer at pH 9.2
with SDS and Brij 35 micelles. The sensitivity obtained
(LOD , 2.4 mg/mL) in addition to the other analytical
characteristics of the method were good enough to pro-
pose this methodology as an alternative to the official
methods of analysis of cephalexin based on micro-
biologic assay and LC. The specificity of the electropho-
retic method was demonstrated analyzing two samples of
cephalexin (a simulated and a commercial sample) and
the corresponding placebo observing that excipients of
the suspension did not interfere with the cephalexin peak
[13]. Figure 4 shows the electropherograms correspond-
ing to a placebo from a simulated cephalexin oral sus-
pension sample (Fig. 4A), a commercial sample (Fig. 4B),
and a simulated sample (Fig. 4C).
The aminoglycoside antibiotic gentamicin was analyzed in
46 bulk samples of different manufacturers or pharmaceu-
tical companies finding different patterns of the main com-
ponents of gentamicin (C1, C1a, C2a, and C2) as well as many
minor products associated to the existence of sisomicin.
Almost all samples analyzed met the requirements estab-
lished by the European and United States Pharmacopeias.
The separation of these compounds was achieved inborate
buffer at pH 10 containing deoxycholate and b-CD. The
detection of gentamicin required a prederivatization step.
Then, samples were derivatized with OPA in presence of
methanol. These solutions after being vortexed and heated
in a water bath at 407C for exactly 4 min were diluted with
methanol and cooled to room temperature prior to the
injection in the CE system [16].
3.2 Antibiotics in biological samples
Biological samples usually contain interferences and
proteinaceous components and particulate matter that
make their analysis difficult. Therefore, a sample treat-
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Table 2. Analysis of antibiotics by CE in different matrices
Application Sample studied Sample treatment Analyte CE conditions Refer-
ence
Pharmaceutical
preparations
Formulations in powder
for preparing injection
solutions and capsules
Direct injection of 20 mM
phosphate buffer (pH 7.0)
solutions (ultrasonication
and filtration of capsules)
Ampicillin Phosphate-borate
(pH 7.5)1 SDS
(UV-200 nm)
[6]
Injection preparation
(Timentin)
Direct injection of water
solutions
Ticarcillin and
clavulanic acid
Phosphate-borate
(pH 8.66)1 SDS
(UV-214 nm)
[12]
Veterinary drugs Direct injection of water
solutions
Penicillin G, dihydro-
streptomycin
Borate (pH 8.0)
(UV-185 nm)
[10]
Capsules and solutions Direct injection of filtered
water samples
Florphenicol,
chloramphenicol,
thiamphenicol
Borate (pH 9.0) 1
SDS (UV-214 nm)
[23]
Oral suspensions Direct injection of water
samples
Cephalexin Borate (pH 9.23)1 SDS1
Brij 35 (UV-210 nm)
[13]
Drugs lots for purity
assessment
Direct injection of derivatized
solution
Gentamicin (OPA
derivatives)
Borate (pH 10.0)1
deoxycholate 1 b-CD
(UV-340 nm)
[15, 16]
Biological
samples
In vitro studies using
the Caco-2 cell
monolayers model
Direct injection of diluted
samples obtained after LLE
Ofloxacin enantiomers Phosphate (pH 2.8) 1
methyl b-CD
(UV-280 nm)
[22]
Plasma and microdialysis
samples
Direct injection (microdialysis
samples). Treatment with
methanol and centrifugation
prior injection (plasma samp-
les)
Fosfomycin Benzoic acid 1 CTAB
(pH 6.95 for plasma
and pH 8.05 for
microdialysis samples)
(indirect UV-254 nm and
contactless conductivity
detection)
[24]
Serum, wound drains,
and cerebrospinal
fluids
Direct injection of filtered
samples (centrifuged and
frosted, being defrosted just
before preparation)
Cefazolin Phosphate (pH 6.8)
(UV-270 nm)
[14]
Human serum Direct injection of water:
methanol (1:1) solutions
obtained after SPE
Gentamicin
(C1, C1a, C2a, C2)
CHES (pH 9.5) 1 methanol
(UV-230 nm)
[25]
Tissue samples from
poultry and porcine
Protein precipitation by ACN
without or with LLE
Amoxicillin, doxycycline,
streptomycin, thiam-
phenicol, florphenicol,
enrofloxacin, cipro-
floxacin, and norfloxacin
Phosphate-borate
(UV-200–280 nm)
[11]
Food samples Pork, chicken, and beef
meat samples
Direct injection of ACN–water
(50:50 v/v) solution after
SLE 1 SPE
Sulfamethazine, sulfame-
razine, sulfadiazine,
sulfadimethoxine,
sulfamonomethoxine,
sulfaphenazole, sulfaqui-
noaline, sulfisoxazole
Phosphate (pH 6.5)
(UV-205 nm)
[20]
Environmental
samples
Farm water samples Direct injection of filtered
water samples
Amoxicillin, ampicillin,
penicillin G, oxacillin,
penicillin V, cloxacillin
Borate (pH 8.5) 1 SDS
(UV-210 nm)
[7]
Groundwater and surface
water samples
Flow manifold coupled
online to CE
Tetracycline, oxytetracy-
cline, doxycycline
Citric acid (pH 2.5)
(UV-260 nm)
[21]
LLE, liquid–liquid extraction; SLE, solid–liquid extraction.
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Figure 4. Analysis of samples of cephalexin oral sus-
pensions by CE: (A) placebo from simulated sample;
(B) commercial sample (oral suspension), 80 mg/mL;
(C) simulated sample (oral suspension), 80 mg/mL. Elec-
trophoretic conditions: fused-silica capillary, ld = 28 cm, lt
= 50 cm, and 75 mm ID; separation buffer, 20 mM borate
(pH 9.23) containing 20 mM SDS and 20 mM Brij 35;
separation temperature, 307C; applied voltage, 15 kV;
sample injection 12.7 cm for 5 s. UV-detection at 210 nm.
Reprinted from [13], with permission.
ment prior to the injection in the CE system is usually
required [1]. Table 2 shows that biological samples
reported in this review were treated by microdialysis,
liquid–liquid extraction (LLE), solid–liquid extraction
(SLE), SPE, centrifugation, and filtration before the injec-
tion in the CE system. In addition, biological fluids such as
plasma and serum are generally easier to handle than
solid samples such as tissue samples.
The quantitation of ofloxacin, which is a chiral fluo-
roquinolone for which the antibacterial activity of S-(2)-
enantiomer is reported to be 8–128 times higher than that
of the R-(1)-form, was achieved in physiological solutions
using phosphate buffer at pH 2.8 and methyl b-CD as
chiral selector. An LLE of ofloxacin with dichloromethane
from physiological solutions (in Hank’s balanced salt so-
lution at pH 7.4) was performed to investigate the
absorption of this antibiotic in in vitro studies (using Caco-
2 cells as absorption model). The quantitation limits
determined for the enantiomers were 11.4 ng/mL for
S-ofloxacin and 10.8 ng/mL for the R-enantiomer [22].
The analysis of fosfomycin in human plasma and micro-
dialysis samples collected from test persons during a
clinical trial was carried out under reversed EOF condi-
tions using benzoic acid and CTAB as BGE adjusted to
pH 6.95 for plasma and to pH 8.05 for microdialysis
samples. Although no sample preparation was needed for
microdialysis samples, for plasma samples, proteins were
precipitated with methanol and after centrifugation the
supernantant was injected in the CE system. LODs
ranged from 0.6 to 2 mg/mL, depending on the matrix and
the detection method (indirect UV-detection at 254 nm
and contactless conductivity detection) [24].
The cephalosporin cefazolin was determined in serum,
contents of wound drains, and cerebrospinal fluid in a 24-
h postoperative period after the administration of 1 g of
the antibiotic just prior to skin incision in patients under-
going lumbar discectomy or craniectomy. The biofluid
samples analyzed were centrifuged and frosted (at
2187C) until their analysis by CE. After defrosting, filtra-
tion through 0.45 mm syringe filters was made prior to the
injection in the CE system. Analysis was performed using
phosphate buffer at pH 6.8 and UV-detection at 270 nm
[14].
The determination of gentamicin components (C1, C1a,
C2a, and C2) in human serum was performed after an SPE
of the sample. A water dilution of the serum sample was
applied to the SPE cartridge (a weak cation exchanger)
and then washed with 20 mM phosphate buffer at pH 7.4,
200 mM borate buffer at pH 9.0, and water, prior to the
elution of gentamicin with ammonia/methanol. Then, after
drying the eluate, it was reconstituted in water–methanol
(1:1) and derivatized with 1,2-phthalic dicarboxaldehyde/
mercaptoacetic acid prior to separation with CHES buffer
at pH 9.5 containing 31.6% methanol and UV-detection
at 230 nm. Under these conditions SPE recoveries rang-
ing from 78 to 93% were obtained and LODs about
0.3 mg/mL for the four gentamicin components were
achieved. Therefore, sufficient sensitivity for the total
gentamicin was achieved by this CE method since the
permitted maximum trough and peak concentrations of
gentamicin in clinical practice are 2 and 10 mg/L,
respectively. Figure 5 depicts the electropherograms
obtained by the SPE-CE method for human serum sam-
ples of patients with concentration of gentamicin of
1.47 mg/L (below the toxic concentration) and 12.3 mg/L
(above the toxic concentration) [25].
The quantitative determination of antibiotic residues in
poultry and porcine tissues for eight of the most frequently
used antibiotics and the drug nifursol (see Table 2) was
achieved by CE after a simple extraction with ACN or ethyl
acetate under basic conditions. Thus, the samples includ-
ing enrofloxacin, ciprofloxacin, norfloxacin, and nifursol
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Figure 5. Analysis by SPE-CE of a human serum with
concentrations of gentamicin of 1.47 mg/L (A) and
12.3 mg/L (B), both containing 5 mg/L of furosemide as
IS. Electrophoretic conditions: fused-silica capillary, ld =
40 cm, lt = 50.2 cm, and 75 mm ID; separation buffer,
60 mM CHES (pH 9.5) containing 31.6% m/v methanol;
separation temperature, 207C; applied voltage, 23 kV;
sample injection, 0.8 psi for 10 s. UV-detection at 230 nm.
Reprinted from [25], with permission.
were only deproteinized by precipitacion of the proteins
using ACN, while the samples containing amoxicillin,
doxycycline, streptomycin, thiamphenicol, and florpheni-
col were deproteinized by ACN and subsequently
extracted with ethyl acetate in the presence of 1 M NaOH.
Then, the organic solvent was evaporated to dryness and
the dry residue was reconstituted in 2 mM borate
(0.5 mL), centrifuged, and injected into the CE system.
The analysis with phosphate-borate buffer and UV-
detection from 200 to 280 nm depending on the antibiotic
enabled to achieve LODs from 3 to 35 ng/mL [11].
3.3 Antibiotics in food samples
Antibiotics orally administered or mixed with animal feed
have been used to prevent and control a number of dis-
eases in veterinary practice. The use of these substances
as well as the maximum residue levels in animal food-
stuffs are regulated because of the concerns about their
possible effects on human health [26]. As a consequence,
the determination of the residue levels in meat and other
animal byproducts (i.e., milk and eggs) used for human
consumption is an important task.
The determination of eight commonly used sulfonamides
(see Table 2) in meat samples was performed by CE using
phosphate buffer at pH 6.5. A solvent extraction with ACN
followed by an SPE procedure for sample cleanup and
preconcentration of sulfonamides was employed prior to
CE analysis. Figure 6 illustrates the electropherograms
corresponding to a sulfonamide (100 mg/kg) spiked beef
sample and a pork sample where the sulfonamine antibi-
otic sulfisoxazole in presence of an IS (1-naphthoxyacetic
acid) was detected. In addition, the detection limits (from
5 to 10 mg/mL) and quantitation limits for this method are
low enough to determine residues of these drugs in meat
samples below the allowed maximum residue limits
established by the European Community [20].
Figure 6. Analysis by CE of a sulfonamide (100 mg/kg)
spiked beef sample (A) and a pork sample (containing
sulfisoxazole (SIA) and 1-naphthoxyacetic acid
(ISTD)) (B). Electrophoretic conditions: fused-silica capil-
lary, ld = 72 cm, lt = 80.5 cm, and 50 mm ID; separation
buffer, 35 mM phosphate (pH 6.5); separation tempera-
ture, 257C; applied voltage, 25 kV; sample injection,
50 mbar for 15 s. UV-detection at 205 nm. Peak identifi-
cation: 1, sulfamethazine, 2, sulfamerazine, 3, sulfadia-
zine, 4, sulfadimethoxine, 5, sulfamonomethoxine, 6, sul-
faphenazole, 7, sulfaquinoaline, 8, sulfisoxazole, 9, 1-
naphthoxyacetic acid. Reprinted from [20], with permis-
sion.
3.4 Antibiotics in environmental samples: their
role as emerging contaminants
The determination of antibiotic residues in environmental
samples is interesting because they are suspected of
being responsible for the appearance of bacterial strains
that are resistant to antibiotics [7]. In addition, it is impor-
tant to consider that the large amount of antibiotics which
are continuously introduced to the environment by
numerous routes make them potential pollutants, called
as emerging pollutants, included in the denominated
pharmaceutical and active ingredients in personal care
products (PPCPs). Regardless of how short their half-lives
in the environment might be, however, all PPCPs can act
as “persistent” pollutants because they are replenished
by the continuous introduction of sewage effluents (http://
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www.epa.gov/nerlesd1/chemistry/ppcp/images/iom-2003.
pdf; checked on May 2005). The most prevalent antibiotics
found in the environment have been macrolide, fluor-
oquinolone, and sulfonamide groups [27]. Although tetra-
cyclines or penicillins have been found only in some
cases and generally at low concentrations, the two appli-
cations found in the literature in the period of time
reviewed in this work are focused on the determination of
these antibiotics in water samples.
The separation and determination of penicillins in farm
water samples were performed by CE using borate buffer
at pH 8.5 with SDS micelles and UV-detection at 210 nm.
In this study, a very simply sample treatment was per-
formed since the water samples were only filtered before
introduction in the CE equipment. Under these conditions
LODs of about 0.2 mg/mL were achieved although, as the
authors indicated, they would be improved if a solid-
phase concentration step is included into the sample
preparation process [7].
Three tetracyclines (tetracycline, oxytetracycline, and
doxycycline) were determined in groundwater and sur-
face water samples after their preconcentration on a
STRATA-X solid-phase minicolumn inserted in a flow
manifold coupled online to CE. Figure 7 shows the elec-
tropherogram corresponding to a water sample spiked
with a 5 ng/mL concentration of each tetracycline deriva-
tive. This CE method enabled the detection up to 2 ng/mL
of tetracyclines in water samples [21].
Figure 7. Analysis by CE of a water sample spiked with
5 ng/mL of each analyte. Electrophoretic conditions:
fused-silica capillary, ld = 37 cm and 75 mm ID; separation
buffer, 50 mM citric acid (pH 2.5); separation tempera-
ture, 257C; applied voltage, 10 kV; sample injection 20 psi
for 10 s. UV-detection at 260 nm. Peak identification:
a, tetracycline; b, oxytetracycline; c, doxycycline. Re-
printed from [21], with permission.
4 Conclusions and future prospects
The separation of mixtures of antibiotics has been suc-
cessfully performed by CE, mainly using MEKC. The lack
of sensitivity for some classes of antibiotics, such as
aminoglycoside antibiotics, has been overcome deriva-
tizing them to form UV-absorbing derivatives or UV-
absorbing borate complexes or using alternative detec-
tion systems. Although detection by direct UV-absorption
of antibiotics or their derivatives was used in most of the
papers included in this review, the use of alternative
detection systems such as MS or electrochemical detec-
tion to solve sensitivity problems for the analysis of some
antibiotics constitute a future prospect in this field.
Although the sample preparation required for the deter-
mination of antibiotics in pharmaceutical preparations
has usually been simple, a more elaborated sample
treatment before the injection in the CE system is
usually needed for the analysis of antibiotics in complex
matrices, i.e., in biological, food, and environmental
samples. In this sense, offline sample treatment by SPE,
LLE, and SLE has been performed. However, the online
coupling of sample treatment systems to CE seems to
be very promising because it enables the automatiza-
tion of the analytical process, one interesting example
being included in this review [21]. In addition, these
sample treatment procedures can concentrate antibiotic
samples prior to the injection in the CE system. It is also
important to remark the interest of the use of on-column
sample preconcentration techniques based on electro-
phoretic principles, such as stacking preconcentration,
which has been achieved very recently for a group of
penicillins [8]. In fact, the achievement of low detection
limits is important for the analysis of biological, food,
and environmental samples. Thus, the maximum resi-
due levels of antibiotics in foods are in the mg/mL level
[26] and the concentrations of antibiotics in environ-
mental samples may range from the mg/mL to the pg/
mL levels.
The development of new applications for antibiotics,
especially in the environmental field where their determi-
nation at low concentration levels has an increasing
interest, is also a future prospect in the analysis of antibi-
otics by CE.
Finally, another trend in analytical chemistry that also
affects the analysis of antibiotics by CE is the transfer of
CE methods to miniaturized systems such as microchips.
As an illustrative example, Fig. 8 shows the separation of
two penicillin antibiotics in seconds when their detection
at the micromolar concentration was performed by
amperometric detection [28].
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Figure 8. Separation of 13 mM ampicillin (AMP) and
12 mM penicillin G (PEN) by CE and pulsed amperometric
detection. CE chip with channels of 50 mm width, 50 mm
deep and sample loop 580 mm long. Separation buffer,
10 mM borate (pH 9.45); applied voltage, 1.7 kV; sample
injection for 10 s. Pulsed amperometric detection using a
potential of 0.5 V. Reprinted from [28], with permission.
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